Company / PP&E per Share
Tvardi Therapeutics, Inc. PP&E per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.06
FY2023
5-year range
$0.01 / $0.06
FY2019-FY2023
Trend
+675.2%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share changed +675% YoY in FY2023, a notable deviation from the 8-year average annual change of +65%.
Based on SEC 10-K filings.
0.06 in FY2023 with a 5-year CAGR of +18.0%.
Improved from $0.01 to $0.06 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +50.9%
- 5-Year CAGR
- +18.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, pp&e per share increased 675.2% year-over-year.
- Lowest pp&e per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0.06 | +675.2% |
| FY2022 | $0.01 | -37.0% |
| FY2021 | $0.01 | -29.6% |
| FY2020 | $0.02 | +1.6% |
| FY2019 | $0.02 | -34.3% |
| FY2018 | $0.03 | -37.5% |
| FY2017 | $0.04 | -27.2% |
| FY2016 | $0.06 | +6.9% |
| FY2015 | $0.06 | -88.6% |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026